Molecular Imaging

Latest News

FDA Approves Multiple New Indications for the Brain PET Imaging Agent Vizamyl
FDA Approves Multiple New Indications for the Brain PET Imaging Agent Vizamyl

June 25th 2025

Expanded indications for the flutemetamol F18 injection include amyloid quantification and monitoring of anti-amyloid treatments.

FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy

June 24th 2025

New Study Shows Impact of Tau-Positive PET in Risk Stratification for Dementia and Alzheimer’s Disease
New Study Shows Impact of Tau-Positive PET in Risk Stratification for Dementia and Alzheimer’s Disease

June 17th 2025

Meta-Analysis Shows Merits of (68Ga)Ga-FAPI-04 PET for Assessing GI Tumors and Metastases
Meta-Analysis Shows Merits of (68Ga)Ga-FAPI-04 PET for Assessing GI Tumors and Metastases

June 13th 2025

FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging

June 11th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.